Suven Life Sciences has informed that it enclosed News Release of our company titled ‘Suven Life Sciences to Present Seven Scientific Posters Highlighting Its CNS Drug Discovery and Development Pipeline at Neuroscience 2026 (SfN), Washington DC, USA’.
The above information is a part of company’s filings submitted to BSE.